Editorial

Are We Ready for Same-Day Pegfilgrastim and Chemotherapy?

Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA Clinical Professor Emeritus, University of California, San Francisco; Professor Emeritus, Touro University–California, Mare Island, Vallejo, CA

JHOP Editorial Board Member, Readers, and Author Interact - Optimizing the Administration of Daratumumab

Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Dr Soefje is Director, Pharmacy Cancer Care, Mayo Clinic, Rochester, MN.

JHOP Editorial Board Member, Readers, and Author Interact - Comment on Kye et al (April 2023), Authors’ Response

Keeping the HOP(A) Live—Annual Conference Research Highlights

By Mark L. Zangardi, PharmD, MS, BCOP; Sara Kim, PharmD, BCOP

Optimal Sequencing of Cancer Treatments an Increasingly Important Question

Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Adoption of Biosimilars—Why the Delay?

Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Online First

Protecting Patients with Cancer During the COVID-19 Pandemic

Robert Mancini, PharmD, BCOP, FHOPA, and Timothy G. Tyler, PharmD, FCSHP, FHOPA

HOP(A) Springs Eternal

By Bryna Delman Ewachiw, PharmD, BCOP; Mark L. Zangardi, PharmD, BCOP

Dosing Chemotherapy in Obese Patients, Still Not Answered

By Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA

Urine Alkalinization and Methotrexate Clearance: Are These Key to Safe Administration of High-Dose Methotrexate?

Joseph Bubalo, PharmD, BCPS, BCOP

Results 1 - 10 of 10

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.